First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

DSpace Repository

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

Author: Smit, Merel J.; Sander, Adam F.; Ariaans, Maud B. P. A.; Fougeroux, Cyrielle; Heinzel, Constanze; Fendel, Rolf; Esen, Meral; Kremsner, Peter G.; ter Heine, Rob; Wertheim, Heiman F.; Idorn, Manja; Underwood, Alexander P.; Binderup, Alekxander; Ramirez, Santseharay; Bukh, Jens; Soegaard, Max; Erdogan, Sayit M.; Gustavsson, Tobias; Clemmensen, Stine; Theander, Thor G.; Microbe, Lancet; Salanti, Ali; Hamborg, Mette; de Jongh, Willem A.; McCall, Matthew B. B.; Nielsen, Morten A.; Mordmuller, Benjamin G.
Tübinger Autor(en):
Heinzel, Constanze
Fendel, Rolf
Esen, Meral
Kremsner, Peter
McCall, Matthew
Published in: Lancet Microbe (2023), Bd. 4, H. 3, S. E140-E148
Verlagsangabe: Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/S2666-5247(22)00337-8
ISSN: 2666-5247
DDC Classifikation: 610 - Medicine and health
570 - Life sciences; biology
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)